Anti-phospho-Parkin (Ser101)

Anti-phospho-Parkin (Ser101)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
609-401-E06 100 µl - -

6 - 10 Werktage*

684,00 €
 
Anti-Parkin pS101 antibody is directed against human Parkin protein. The antibody was affinity... mehr
Produktinformationen "Anti-phospho-Parkin (Ser101)"
Anti-Parkin pS101 antibody is directed against human Parkin protein. The antibody was affinity purified from monospecific antiserum by immunoaffinity purification and is specific for the phophorylated protein. Immunolabeling of the parkin band is absent in parkin S101 mutants. Reactivity is expected from the following species based on 100% sequence homology: bovine and non-human primates. Cross reactivity with Parkin from other species has not been determined. Protein function: Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins, such as BCL2, SYT11, CCNE1, GPR37, STUB1, a 22 kDa O-linked glycosylated isoform of SNCAIP, SEPT5, ZNF746 and AIMP2. Mediates monoubiquitination as well as 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of substrates depending on the context. Participates in the removal and/or detoxification of abnormally folded or damaged protein by mediating 'Lys-63'-linked polyubiquitination of misfolded proteins such as PARK7: 'Lys-63'- linked polyubiquitinated misfolded proteins are then recognized by HDAC6, leading to their recruitment to aggresomes, followed by degradation. Mediates 'Lys-63'-linked polyubiquitination of SNCAIP, possibly playing a role in Lewy-body formation. Mediates monoubiquitination of BCL2, thereby acting as a positive regulator of autophagy. Promotes the autophagic degradation of dysfunctional depolarized mitochondria. Mediates 'Lys-48'-linked polyubiquitination of ZNF746, followed by degradation of ZNF746 by the proteasome, possibly playing a role in role in regulation of neuron death. Limits the production of reactive oxygen species (ROS). Loss of this ubiquitin ligase activity appears to be the mechanism underlying pathogenesis of PARK2. May protect neurons against alpha synuclein toxicity, proteasomal dysfunction, GPR37 accumulation, and kainate-induced excitotoxicity. May play a role in controlling neurotransmitter trafficking at the presynaptic terminal and in calcium-dependent exocytosis. Regulates cyclin-E during neuronal apoptosis. May represent a tumor suppressor gene. [The UniProt Consortium]
Schlagworte: Anti-phospho-PRKN, Anti-phospho-PARK2, EC=6.3.2.-, Anti-phospho-Parkinson disease protein 2, Anti-phospho-E3 ubiquitin-protein ligase parkin, Anti-phospho-Parkinson juvenile disease protein 2
Hersteller: Rockland Immunochemicals
Hersteller-Nr: 609-401-E06

Eigenschaften

Anwendung: WB
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Immunogen: synthetic phospho-peptide corresponding to amino acid residues surrounding Ser101.
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-phospho-Parkin (Ser101)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen